A propos of all the recent discussions/debates about MGD, please note this Eyeworld quickie report from a presentation by Dr. McCulley at the ASCRS meeting going on in Hawaii.
Emphasis mine.
Emphasis mine.
Discussing the classification of blepharitis, James McCulley, M.D., noted four basic types: staphylococcal, seborrheic, primary meibomitis (MKC), and meibomian gland dysfunction. The pathophysiology of chronic blepharitis can be attributed to both biochemical abnormalities of the meibum as well as bacterial lipolytic exoenzymes, but not to a single bacterium.
Dr. McCulley stressed that therapy should not be used to cure the disease but to provide relief and control.
Mechanical and hygienic measures include hot compresses, massage, and lid scrubs.
Recommended topical antibiotic treatments include bacitracin, fluoroquinolones, aminoglycides, and tetracyclines.
Systemic antibiotics are only indicated in severe cases of acute bacterial blepharitis, secondary meibomianitis, and MKC. Recommended systemic antibiotics include tetracycline analogues (including minocycline), and macrolides.
Dr. McCulley stressed that therapy should not be used to cure the disease but to provide relief and control.
Mechanical and hygienic measures include hot compresses, massage, and lid scrubs.
Recommended topical antibiotic treatments include bacitracin, fluoroquinolones, aminoglycides, and tetracyclines.
Systemic antibiotics are only indicated in severe cases of acute bacterial blepharitis, secondary meibomianitis, and MKC. Recommended systemic antibiotics include tetracycline analogues (including minocycline), and macrolides.
Comment